Levofloxacin Injection, Solution, Concentrate
Product Images NDC 55150-157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 55150-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Fig1)

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Fig1)
The figure shows the comparison of mean levofloxacin plasma concentration over time for a 750mg tablet taken orally and a 750mg dose administered through a 90-minute infusion. The plasma concentration is measured in μg/mL.*
FDA Label Image

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Fig2)

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Fig2)
This is a graph (Figure 3) displaying the mean Levofloxacin plasma concentration (in meg/mL) versus time for a 500 mg dose. The data seems to have been obtained through both oral (p.o.) and intravenous (iv.) administration of 500 mg of the drug.*
FDA Label Image

Package Label-principal Display Panel (500 mg per 20 mL Container Label)

FDA Label Image

Package Label-principal Display Panel (500 mg per 20 mL Container-Carton (1 Vial))

Package Label-principal Display Panel (500 mg per 20 mL Container-Carton (1 Vial))
This is information about Levofloxacin, an injectable drug. The contents of the single-dose vial must be diluted before intravenous administration. It is not for direct infusion. The drug must be discarded after use. Each vial contains concentrated solution equivalent to 500 mg of Levofloxacin. The pH range of the solution is 3.8 to 5.8. The vial stopper is not made with natural rubber latex. The drug should be stored between 20°C to 25°C (68°F to 77°F). The drug is distributed by AuroMedics Pharma LLC, and the product is made in India.*
FDA Label Image

Package Label-principal Display Panel (750 mg per 30 mL Container Label)

Package Label-principal Display Panel (750 mg per 30 mL Container Label)
This is a set of directions for the usage of Levofloxacin, a concentrated solution distributed by AuroMedics Pharma LLC. The solution needs to be diluted before intravenous administration. The vial contains 750 mg of Levofloxacin USP and may contain diluted Hydrochloric Acid or Sodium Hydroxide for pH adjustment. The Pharmacist should dispense the accompanying Medication Guide to the patient. The solution should be stored at room temperature (20° to 25°C).*
FDA Label Image

Package Label-principal Display Panel (750 mg per 30 mL Container-Carton (1 Vial))

Package Label-principal Display Panel (750 mg per 30 mL Container-Carton (1 Vial))
Levofloxacin Injection is available in single-dose vials with 500 mg of levofloxacin USP. Before intravenous administration, the vial contents must be further diluted with an appropriate solution. Refer to the insert for preparation guidelines, storage, stability, compatibility, and dosage. Levofloxacin Injection's pH range is 3.8-5.8 and can contain diluted Hydrochloric Acid, NF, and/or Sodium Hydroxide, NF, for pH adjustment. Each vial is not made with natural rubber latex and should be stored at 20°C to 25°C (68°F to 77°F). Retain in Carton until time of use. The accompanying medication guide should be dispensed to each patient.*
FDA Label Image

Chemical Structure (Levofloxacin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.